Answers are grounded in this paper and cite their sources.
Clinical study assesses treatment outcomes and relapse factors in adults with Minimal Change Disease, indicating a need for improved management strategies.
Minimal Change Disease (MCD), accounts for 10–15% of primary nephrotic syndrome cases in adults. Limited studies have examined its clinical characteristics, treatment outcomes, and relapse factors in adults, particularly in low-income countries like Ethiopia. This study aimed to assess the treatment outcomes, and factors associated with relapse among adult patients with MCD at St. Paul’s Hospital Millennium Medical College in Addis Ababa, Ethiopia.
No takes yet. Share an insight, caveat, or question.
Tesfaye et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: